Suppr超能文献

萘普生钠与对乙酰氨基酚/右丙氧芬用于运动损伤——一项多中心对比研究

Naproxen sodium and paracetamol/dextropropoxyphene in sports injuries - a multicentre comparative study.

作者信息

Simmons R L, Owen S, Abbott C J, Bouchier-Hayes T A, Hunt H A

出版信息

Br J Sports Med. 1982 Jun;16(2):91-5. doi: 10.1136/bjsm.16.2.91.

Abstract

This paper follows up a previous paper reported in this journal. This study was a single-blind parallel comparison of naproxen sodium ("Synflex") and a paracetamol/dextropropoxyphene combination ("Distalgesic"). It was carried out in 184 patients suffering from soft-tissue disorders recruited from four centres. More patients were considered cured and the pain score was significantly lower after seven days' treatment in the naproxen sodium ("NS") group. For those patients who received 14 days' treatment the total symptom score was significantly lower in the naproxen sodium group at the end of treatment. Two patients in the NS treatment group withdrew from the study due to lack of efficacy. Fewer side-effects were reported in the NS group. Of the eight patients stopping treatment due to side-effects, two were in the naproxen sodium group and six in the paracetamol/dextropropoxyphene ("control") group. The results suggest that a better clinical response to treatment and fewer side-effects may be obtained with naproxen sodium than with paracetamol/dextropropoxyphene in the treatment of soft-tissue injuries.

摘要

本文是对发表在本期刊上的一篇前文的跟进。本研究是萘普生钠(“Synflex”)与对乙酰氨基酚/右旋丙氧芬组合制剂(“Distalgesic”)的单盲平行对照试验。研究在从四个中心招募的184名患有软组织疾病的患者中开展。在萘普生钠(“NS”)组,经过七天治疗后,更多患者被认为治愈,且疼痛评分显著更低。对于接受14天治疗的患者,在治疗结束时,萘普生钠组的总症状评分显著更低。NS治疗组有两名患者因疗效不佳退出研究。NS组报告的副作用更少。在因副作用而停止治疗的八名患者中,两名在萘普生钠组,六名在对乙酰氨基酚/右旋丙氧芬(“对照”)组。结果表明,在治疗软组织损伤方面,萘普生钠比之对乙酰氨基酚/右旋丙氧芬可能能获得更好的临床治疗反应且副作用更少。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8467/1859119/4d270427088a/brjsmed00250-0021-a.jpg

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验